Mingxiao He
Director, Bioprocessing & Manufacturing Eureka Therapeutics
Mingxiao He is Director of Bioprocessing and Manufacturing at Eureka Therapeutics, where she drives process development and clinical manufacturing to support next-generation immunotherapies. With a Ph.D. in Immunology from Duke University, Mingxiao began her career in bioprocessing research and has over 15 years of experience spanning process development, cell therapy manufacturing, and leadership roles in biotech. Her work bridges scientific innovation with scalable manufacturing, advancing cutting-edge therapies toward clinical impact. Mingxiao’s expertise enhances both operational excellence and therapeutic translation in cell-based medicine.
Seminars
Wednesday 15th July 2026
Panel Discussion: Implementing Automation in Process Development While Maintaining Critical Quality Attributes & Product Consistency Across Manufacturing Scales
11:40 am
- Balancing automation benefits including reduced variability and increased throughput against potential risks to product quality during technology transitions
- Establishing robust quality control strategies and in-process monitoring to ensure automated systems maintain or exceed manual process quality standards
- Navigating vendor selection and validation challenges to identify automation platforms that preserve critical quality attributes while improving manufacturing efficiency
